The Bronx, NY2 Active Studies

Chronic Myeloid Leukemia Clinical Trials in The Bronx, NY

Find 2 actively recruiting chronic myeloid leukemia clinical trials in The Bronx, NY. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
290
Enrolling

Recruiting Chronic Myeloid Leukemia Studies in The Bronx

About Chronic Myeloid Leukemia Clinical Trials in The Bronx

Chronic myeloid leukemia (CML) is a type of cancer that starts in blood-forming cells of the bone marrow, characterized by the Philadelphia chromosome and BCR-ABL fusion gene. It was one of the first cancers treated successfully with targeted therapy. Tyrosine kinase inhibitors like imatinib have transformed CML into a manageable chronic condition.

There are currently 2 chronic myeloid leukemia clinical trials recruiting participants in The Bronx, NY. These studies are seeking a combined 290 participants. Research is being sponsored by Enliven Therapeutics, M.D. Anderson Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.

Chronic Myeloid Leukemia Clinical Trials in The Bronx — FAQ

Are there chronic myeloid leukemia clinical trials in The Bronx?

Yes, there are 2 chronic myeloid leukemia clinical trials currently recruiting in The Bronx, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in The Bronx?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the The Bronx research site will contact you about next steps.

Are clinical trials in The Bronx free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many The Bronx studies also compensate for your time and travel.

What chronic myeloid leukemia treatments are being tested?

The 2 active trials in The Bronx are testing new therapies including novel drugs, biologics, and treatment approaches for chronic myeloid leukemia.

Data updated October 15, 2026 from ClinicalTrials.gov